Figure 1 | Scientific Reports

Figure 1

From: Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience

Figure 1

Time course of thyroglobulin (Tg) in patients with controlled (stable disease or partial response; left) or progressive disease (right).

All patients display an initial decline in Tg after initiation of treatment with lenvatinib. Whereas the patients with long-term disease control present with transient fluctuations in Tg levels (left) over time, Tg rises (continuously) in the subjects with truly progressive disease (right).

Back to article page